May 1 |
Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
|
Apr 30 |
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
|
Apr 30 |
Pfizer, Genmab cervical cancer therapy wins full FDA approval
|
Apr 29 |
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
|
Apr 29 |
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
|
Apr 16 |
Genmab Acquires A Missing Piece For Its Pipeline
|
Apr 16 |
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
|
Apr 15 |
Roche reports survival data for new dual-acting lymphoma drug
|
Apr 15 |
Transactions in Connection with Share Buy-back Program Genmab
|